Adlai Nortye Group (ANL) vs CryoPort (CYRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Adlai Nortye Group (ANL) has outperformed CryoPort (CYRX) over the past year, gaining 712.1% versus a gain of 68.0%. Adlai Nortye Group is the larger company by market cap ($998.8 million vs $856.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANL | CYRX |
|---|---|---|
| Share price | $15.51 | $16.90 |
| Market cap | $998.81M | $855.97M |
| 1-day change | +10.39% | -2.59% |
| YTD return | +889.44% | +76.04% |
| 1-year return | +712.14% | +67.99% |
| 5-year return | — | -75.95% |
| EPS (TTM) | $-0.66 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.25 | $18.36 |
| 52-week low | $0.879 | $7.61 |
| Distance from 52-week high | -10.09% | -7.95% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +90.20% | +16.39% |
| Average volume | 175.26K | 632.63K |
| Shares outstanding | 58.73M | 50.65M |
| Employees | 109 | 684 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANL has outperformed CYRX by 644.1 percentage points over the past year.
About Adlai Nortye Group
ANL stock →Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 109 employees
About CryoPort
CYRX stock →Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
Health Care · Biotechnology: Pharmaceutical Preparations · 684 employees
ANL vs CYRX FAQ
Which is bigger, Adlai Nortye Group or CryoPort?
Adlai Nortye Group (ANL) is larger, with a market capitalization of $998.81M compared with $855.97M for CryoPort (CYRX).
Which stock has performed better over the past year, ANL or CYRX?
ANL returned +712.14% over the past 12 months, compared with +67.99% for CYRX (price return, excluding dividends). Past performance does not predict future results.
Are Adlai Nortye Group and CryoPort in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.